“I partially blame the people who called leronlimab a scam for months, suppressing enrollment in the trials. We could have been done by now.”

This has nothing to do with slow enrollment. The majority of COVID19 patients and doctors then, and now, do not know about leronlimab and it’s potential. Enrollment was slow for that reason. Enrollment increased, dramatically, because CYDY our boots on the ground and informed patients and doctors about leronlimab. Articles and individuals bashing the drug did not impact enrollment.